Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07669012Phase 1Recruiting
Phase 1, randomised trial in sedation comparing Group KP: Ketamine + Propofol with Group DP: Dexmedetomidine + Propofol (2 arms). Primary endpoint: Incidence of respiratory complications at 2 hours. Started Oct 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07669012.